TickerFactsScreenerDevelopers

Tempest Therapeutics, Inc. (TPST) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $4.54M2012: $14.78M2013: $18.08M2014: $6.41M2015: $43.22M2016: $43.93M2017: $17.58M2018: $73.29M2019: $62.48M2020: $18.82M2021: $51.83M2022: $31.23M2023: $39.23M2024: $30.27M2025: $7.71M$7.71M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$7.71M-74.5%
2024$30.27M-22.8%
2023$39.23M+25.6%
2022$31.23M-39.7%
2021$51.83M+175.4%
2020$18.82M-69.9%
2019$62.48M-14.7%
2018$73.29M+316.9%
2017$17.58M-60.0%
2016$43.93M+1.6%
2015$43.22M+573.9%
2014$6.41M-64.5%
2013$18.08M+22.3%
2012$14.78M+225.4%
2011$4.54M—